Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Galmed Pharmaceuticals Lt...

    NASDAQ: GLMD · Real-Time Price · USD
    1.51
    0.02 (1.34%)
    At close: Jun 06, 2025, 3:59 PM
    1.51
    -0.03%
    After-hours: Jun 06, 2025, 05:51 PM EDT

    Galmed Pharmaceuticals Statistics

    Share Statistics

    Galmed Pharmaceuticals has 2.26M shares outstanding. The number of shares has increased by -72.43% in one year.

    Shares Outstanding

    n/a
    		 2.26M

    Shares Change (YoY)

    n/a
    		 -72.43%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,452

    FTD / Avg. Volume

    n/a
    		 0.06%

    Short Selling Information

    The latest short interest is 188.2K, so 8.33% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 188.2K

    Short % of Shares Out

    n/a
    		 8.33%

    Short % of Float

    n/a
    		 8.59%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.4 and the forward PE ratio is -1.76. Galmed Pharmaceuticals's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.4

    Forward PE

    n/a
    		 -1.76

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 0.18

    P/FCF Ratio

    n/a
    		 -0.5

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Galmed Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.42, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 7.42

    Quick Ratio

    n/a
    		 7.42

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 -418.53

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,505,666.67

    Employee Count

    n/a
    		 3

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -64.61% in the last 52 weeks. The beta is 0.51, so Galmed Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.51

    52-Week Price Change

    n/a
    		 -64.61%

    50-Day Moving Average

    n/a
    		 1.4

    200-Day Moving Average

    n/a
    		 2.93

    Relative Strength Index (RSI)

    n/a
    		 55.03

    Average Volume (20 Days)

    n/a
    		 2,417,012

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -83K

    Operating Income

    n/a
    		 -6.28M

    Net Income

    n/a
    		 -7.52M

    EBITDA

    n/a
    		 -7.42M

    EBIT

    n/a
    		 -7.5M

    Earnings Per Share (EPS)

    n/a
    		 -8.08
    Full Income Statement

    Balance Sheet

    The company has 4.65M in cash and 0 in debt, giving a net cash position of 4.65M.

    Cash & Cash Equivalents

    n/a
    		 4.65M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -200.47M

    Total Assets

    n/a
    		 18.5M

    Working Capital

    n/a
    		 13.95M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -5.88M and capital expenditures 0, giving a free cash flow of -5.88M.

    Operating Cash Flow

    n/a
    		 -5.88M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -5.88M

    FCF Per Share

    n/a
    		 -6.32
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    GLMD does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for GLMD.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 30, 2024. It was a backward split with a ratio of 1:12.

    Last Split Date

    n/a
    		 Aug 30, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:12

    Scores

    Altman Z-Score

    n/a
    		 -14.82

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist